Design, synthesis and biological screening of 2-aminobenzamides as selective HDAC3 inhibitors with promising anticancer effects

The Global Burden of Cancer 2013

Christina Fitzmaurice, Daniel Dicker, Amanda Pain et al. · JAMA Oncology · 2015 · 2.8K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Molecular Evolution of the Histone Deacetylase Family: Functional Implications of Phylogenetic Analysis

IvanV Gregoretti, Yunmi Lee, Holly V. Goodson · Journal of Molecular Biology · 2004 · 1.5K citations

Life Sciences, Genetics, Molecular Biology +14

FDA Approval Summary: Vorinostat for Treatment of Advanced Primary Cutaneous T-Cell Lymphoma

Bhupinder Mann, John R. Johnson, Martin H. Cohen et al. · The Oncologist · 2007 · 1.4K citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Histone Deacetylase 3 (HDAC3) and Other Class I HDACs Regulate Colon Cell Maturation and p21 Expression and Are Deregulated in Human Colon Cancer

Andrew J. Wilson, Do-Sun Byun, Lucas B. Murray et al. · Journal of Biological Chemistry · 2006 · 581 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study

Owen A. O’Connor, Steven M. Horwitz, Tamás Masszi et al. · Journal of Clinical Oncology · 2015 · 547 citations · Full text

Medicine, Oncology, Pharmacotherapy +15